Treponema pallidum is a spirochaete bacterium with subspecies that cause the diseases syphilis, bejel, and yaws. It is a helically coiled microorganism usually 6–15 µm long and 0.1–0.2 µm wide.
This report contains market size and forecasts of Treponema Pallidum Tests in Global, including the following market information:
Global Treponema Pallidum Tests Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Treponema Pallidum Tests market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Treponemal Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Treponema Pallidum Tests include BD, Roche, Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories, BioMerieux, Fujirebio, Thermo Fisher Scientific and Trinity Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Treponema Pallidum Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Treponema Pallidum Tests Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Treponema Pallidum Tests Market Segment Percentages, by Type, 2021 (%)
Treponemal Tests
Non-Treponemal Tests
Global Treponema Pallidum Tests Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Treponema Pallidum Tests Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Global Treponema Pallidum Tests Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Treponema Pallidum Tests Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Treponema Pallidum Tests revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Treponema Pallidum Tests revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD
Roche
Abbott Laboratories
Siemens Healthineers
Bio-Rad Laboratories
BioMerieux
Fujirebio
Thermo Fisher Scientific
Trinity Biotech
Cardinal Health
Arlington Scientific
Tecan Group
DiaSorin
Tulip Diagnostics
Omega Diagnostics
Rapid Labs
Lorne Laboratories
Werfen Holding
Sekisui Medical